PRLD logo

PRLDPrelude Therapeutics Inc

$4.11
$0.16
(4.05%)
Today
Closed $4.11
$0.2262
(5.50%)
After Hours
Updated: 04:33 PM EDT
EarningsAug 13
Mkt Cap$314.6M
Vol204,867.00

About

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
79

Frequently Asked Questions

What is Market Cap of Prelude Therapeutics Inc?
What is the 52-week high for Prelude Therapeutics Inc?
What is the 52-week low for Prelude Therapeutics Inc?
What is Prelude Therapeutics Inc stock price today?
What was Prelude Therapeutics Inc stock price yesterday?
What is the PE ratio of Prelude Therapeutics Inc?
What is the Price-to-Book ratio of Prelude Therapeutics Inc?
What is the 50-day moving average of Prelude Therapeutics Inc?
How many employees does Prelude Therapeutics Inc have?

Advertisement|Remove ads.